Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Equibles does not estimate personal net worth.
Mark Zekulin was last confirmed as CEO at Canopy Growth Corp (CGC) in a filing dated August 7, 2020. The proxy statement of Canopy Growth Corp reports total compensation of $4,542,119 for Mark Zekulin in fiscal 2019, including a base salary of $381,150. Disclosed compensation is on record for 2 fiscal years. Mark Zekulin has spoken on 2 earnings calls across 1 company, most recently for Canopy Growth Corp on September 30, 2019. The companies whose calls Mark Zekulin spoke on are classified in the Healthcare sector.
“So a little bit of, I guess, housekeeping before we start; last quarter I took the time to have a lengthy introduction to go over our strategy, remind people what it was and then confirm we're staying true to it.”
“So as usual, I'd like to begin the call with a brief summary of our objectives as a Company, and then speak to our execution as it relates to those objectives. I will also discuss how that execution translates into our financial performance and highlight our broad expectations heading into the future.”
Start not stated–2020-08-07
Last confirmed by a filing; no departure on record
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Canopy Growth Corp (CGC) | Former Chief Executive Officer | $381,150 | $4,542,119 |
| 2018 | Canopy Growth Corp (CGC) | Former Chief Executive Officer | $231,971 | $1,897,184 |